[go: up one dir, main page]

AP2002002673A0 - Thiazolidinedione salt for the treatment of diabetes mellitus. - Google Patents

Thiazolidinedione salt for the treatment of diabetes mellitus.

Info

Publication number
AP2002002673A0
AP2002002673A0 APAP/P/2002/002673A AP2002002673A AP2002002673A0 AP 2002002673 A0 AP2002002673 A0 AP 2002002673A0 AP 2002002673 A AP2002002673 A AP 2002002673A AP 2002002673 A0 AP2002002673 A0 AP 2002002673A0
Authority
AP
ARIPO
Prior art keywords
treatment
diabetes mellitus
compound
thiazolidinedione
salt
Prior art date
Application number
APAP/P/2002/002673A
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2002002673A0 publication Critical patent/AP2002002673A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A novel pharmaceutical compound 5-[4-[2-(Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydrobromide or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
APAP/P/2002/002673A 2000-06-08 2001-06-08 Thiazolidinedione salt for the treatment of diabetes mellitus. AP2002002673A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
AP2002002673A0 true AP2002002673A0 (en) 2002-12-31

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002673A AP2002002673A0 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for the treatment of diabetes mellitus.

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NO20025883L (en) 2003-02-03
CN1443186A (en) 2003-09-17
NO20025883D0 (en) 2002-12-06
BR0111536A (en) 2003-07-01
KR20030007918A (en) 2003-01-23
OA12284A (en) 2003-11-10
PL360592A1 (en) 2004-09-20
IL153279A0 (en) 2003-07-06
ZA200209954B (en) 2003-10-10
HUP0301137A2 (en) 2003-08-28
HUP0301137A3 (en) 2005-04-28
BG107357A (en) 2003-08-29
DZ3382A1 (en) 2001-12-13
CZ20023966A3 (en) 2003-04-16
AU2001264078A1 (en) 2001-12-17
MXPA02012100A (en) 2003-04-25
MA25753A1 (en) 2003-04-01
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
WO2001094344A1 (en) 2001-12-13
SK17142002A3 (en) 2003-10-07
GB0014006D0 (en) 2000-08-02
EP1296980A1 (en) 2003-04-02
CA2411065A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
WO2000063205A3 (en) Thiazolidinedione derivative and its use as antidiabetic
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
YU16303A (en) Tartarate salts of thiazolidinedione derivative
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
DK1349855T3 (en) 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolidin-2,4-dionmesylatsalt
GB0021784D0 (en) Novel pharmaceutical
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AU2001284274A1 (en) A thiazolidinedione derivative and its use as antidiabetic
PT1446404E (en) EDISILATES OF ROSIGLITAZONE AND ITS USE AS ANTIDIABETICS
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
NZ524933A (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
SI1448559T1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient